Cargando…
Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice
TGF-β signaling in liver cells has variant roles in the dynamics of liver diseases, including hepatocellular carcinoma (HCC). We previously found a correlation of high levels of the important endogenous negative TGF-β signaling regulator SMAD7 with better clinical outcome in HCC patients. However, t...
Autores principales: | Feng, T, Dzieran, J, Yuan, X, Dropmann, A, Maass, T, Teufel, A, Marhenke, S, Gaiser, T, Rückert, F, Kleiter, I, Kanzler, S, Ebert, M P, Vogel, A, ten Dijke, P, Dooley, S, Meindl-Beinker, N M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294248/ https://www.ncbi.nlm.nih.gov/pubmed/28134936 http://dx.doi.org/10.1038/oncsis.2016.85 |
Ejemplares similares
-
Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines
por: Dzieran, Johanna, et al.
Publicado: (2013) -
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
por: Dewidar, Bedair, et al.
Publicado: (2019) -
Distinct dedifferentiation processes affect caveolin-1 expression in hepatocytes
por: Meyer, Christoph, et al.
Publicado: (2013) -
Controlling Smad4 signaling with a Wip
por: ten Dijke, Peter, et al.
Publicado: (2020) -
Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers
por: Qian, Yuquan, et al.
Publicado: (2022)